EKSO Q2 2024 Earnings — Ekso Bionics Holdings, Inc. Revenue & Financial Results | Market Cap Arena

EKSOEkso Bionics Holdings, Inc.

$29M

Q2 2024 Earnings

Healthcare Medical - Instruments & Supplies

Income Statement

Revenue

$5M+5.3% YoY

Gross Profit

$3M53.3% margin

Operating Income

-$2M-47.2% margin

Net Income

-$2M-48.8% margin

EPS (Diluted)

$-0.13

QoQ Revenue Growth

+31.8%

Cash Flow

Operating Cash Flow

-$3M

Free Cash Flow

-$3M

Stock-Based Comp.

$368,000

Balance Sheet

Total Assets

$27M

Total Liabilities

$15M

Stockholders' Equity

$12M

Cash & Equivalents

$6M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$5M	$5M	+5.3%
Gross Profit	$3M	$2M	+17.0%
Operating Income	-$2M	-$4M	+45.5%
Net Income	-$2M	-$4M	+42.9%

Revenue Segments

Product

$4M77%

Service

$836,00017%

Product and Service, Other

$153,0003%

Subscription

$146,0003%

Geographic Segments

Americas

$3M29%

UNITED STATES

$3M26%

EMEA

$2M15%

FRANCE

$522,0005%

Asia Pacific

$515,0005%

GERMANY

$418,0004%

EMEA Other

$338,0003%

CANADA

$330,0003%

INDONESIA

$301,0003%

ROMANIA

$181,0002%

HONG KONG

$108,0001%

APAC Other

$106,0001%

POLAND

$57,0001%